Dr. Wilky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Sylvester Comprehensive Cancer Center at the University of Miami
1475 Nw 12th Ave, Suite 3300
Miami, FL 33136Phone+1 305-243-1000Fax+1 305-243-1293- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012- Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
Rutgers Robert Wood Johnson Medical SchoolClass of 2006
Certifications & Licensure
CO State Medical License 2018 - 2025
FL State Medical License 2013 - 2019
MD State Medical License 2009 - 2013- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award ASCO/Conquer Cancer Foundation, 2012
- Alpha Omega Alpha, Medical Honor Society 2004
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Start of enrollment: 2016 Apr 19
- AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Subjects With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy Start of enrollment: 2016 Apr 01
- Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer Start of enrollment: 2017 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.Fontebasso, A., Rytlewski, J., Blay, J., Gladdy, R., Wilky, B.> ;Surgical Oncology Clinics of North America. 2024 Apr 1
- 1 citationsAfamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia, Jean-Yves Blay, Irene Carrasco Garcia, John A Charlson, Edwin Choy, George D Dem...> ;Lancet. 2024 Apr 13
- RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.Randolph, M., Afifi, M., Gorthi, A., Weil, R., Weinreb, J., Ciero, P., Hoeve, N., van Diest, P., Raman, V., Bishop, A., Loeb, D., Wilky, B.> ;Iscience. 2024 Feb 16
- Join now to see all
Lectures
- Phase I open-label, ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies: Dose selection for combination with PD-1 bloc...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS).2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Complete BibliographyWilky BA
http://www.ncbi.nlm.nih.gov/sites/myncbi/1VYg-8UHXVF5x/bibliography/48190547/public/?sort=date&direction=ascending
Press Mentions
Agenus (AGEN) Q1 2023 Earnings Call TranscriptMay 9th, 2023- Agenus Inc (AGEN) Q2 2020 Earnings Call TranscriptAugust 6th, 2020
Deciphera Pharmaceuticals, Inc. To Present Data from DCC-3014 and Ripretinib Programs at the Connective Tissue Oncology Society (CTOS) 2019 Annual MeetingNovember 13th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Connective Tissue Oncology SocietyMember
- Children's Oncology GroupMember
- Sarcoma Alliance for Research through Collaboration (SARC)Member
Hospital Affiliations
University of Colorado HospitalAurora, Colorado
External Links
- Sarcoma Programhttp://sylvester.org/cancer/bone-and-soft-tissue
- Linked Inhttps://www.linkedin.com/pub/breelyn-wilky-md/55/2a/0
- Bloghttp://breelynwilkymd.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
